• No results found

wild type HIV-1 protease

AN IN SILICO STUDY ON HIV 1 PROTEASE WILD TYPE AND MUTANT WITH INHIBITORS FROM ANNONA SQUAMOSA

AN IN SILICO STUDY ON HIV 1 PROTEASE WILD TYPE AND MUTANT WITH INHIBITORS FROM ANNONA SQUAMOSA

... thrive. HIV-1 protease is a retroviral aspartyl protease (retropepsin) that is essential for the life-cycle of HIV, the retrovirus that causes ...AIDS. HIV Wild ...

8

Maintenance of the Gag/Gag-Pol Ratio Is Important for Human Immunodeficiency Virus Type 1 RNA Dimerization and Viral Infectivity

Maintenance of the Gag/Gag-Pol Ratio Is Important for Human Immunodeficiency Virus Type 1 RNA Dimerization and Viral Infectivity

... virus type 1 (HIV-1) Gag-Pol precursor protein results from a ⴚ 1 ribosomal frameshifting ...on HIV-1 repli- cation and viral assembly, we altered the Gag/Gag-Pol ratio in ...

8

In virio SHAPE analysis of tRNALys3 annealing to HIV 1 genomic RNA in wild type and protease deficient virus

In virio SHAPE analysis of tRNALys3 annealing to HIV 1 genomic RNA in wild type and protease deficient virus

... in wild type viruses [17, ...from wild type or Pr- viruses that correlate with these ...in protease-negative virions than in wild type vi- rions (17, ...

10

Altered Substrate Specificity of Drug-Resistant Human Immunodeficiency Virus Type 1 Protease

Altered Substrate Specificity of Drug-Resistant Human Immunodeficiency Virus Type 1 Protease

... and HIV PRs 945 and 1049 each had a V82A ...in HIV PR 945 was reverted to the wild-type residue, ...variant, HIV PR 945/A82V, was assayed using both the P1-Met library and the ...

10

Autoprocessing of human immunodeficiency virus type 1 protease miniprecursor fusions in mammalian cells

Autoprocessing of human immunodeficiency virus type 1 protease miniprecursor fusions in mammalian cells

... of protease activity and/or autoprocessing ...pseudo wild-type HIV protease construct (Figure 2B lane 13), whereas VLPs produced by the D25N mutant contained only the full length Gag ...

10

Cysteine 95 and other residues influence the regulatory effects of Histidine 69 mutations on Human Immunodeficiency Virus Type 1 protease autoprocessing

Cysteine 95 and other residues influence the regulatory effects of Histidine 69 mutations on Human Immunodeficiency Virus Type 1 protease autoprocessing

... pseudo wild type protease sequence abolishes protease autoproces- sing in ...conserved HIV-1 protease cysteines are not required for the catalytic activity, nor ...

8

High Frequencyof Non-B HumanImmunodeficiency VirusType 1 (HIV-1)SubtypeSpecific Mutationsat theProtease GeneamongTreatment-naiveHIV-1 InfectedIndividualsinJos,Nigeria

High Frequency of Non-B Human Immunodeficiency Virus Type 1 (HIV-1) Subtype Specific Mutations at the Protease Gene among Treatment-naive HIV-1 Infected Individuals in Jos, Nigeria

... from HIV infection globally ...the HIV infected population [12]. The Nigerian national guidelines for HIV/AIDS treatment and care in adolescent and adults recommended boosted protease ...

14

Identification of Biased Amino Acid Substitution Patterns in Human Immunodeficiency Virus Type 1 Isolates from Patients Treated with Protease Inhibitors

Identification of Biased Amino Acid Substitution Patterns in Human Immunodeficiency Virus Type 1 Isolates from Patients Treated with Protease Inhibitors

... in HIV-1 subtype B protease from un- treated ...that HIV-1 variants with every possible amino acid substitution are produced daily in HIV-1- infected individuals ...those ...

6

Defining the level of human immunodeficiency virus type 1 (HIV-1) protease activity required for HIV-1 particle maturation and infectivity.

Defining the level of human immunodeficiency virus type 1 (HIV-1) protease activity required for HIV-1 particle maturation and infectivity.

... in wild-type virions (8, 29, ...that protease inhibitor-treated viruses containing decreased amounts of pro- cessed polyproteins and reverse transcriptase activity are not able to direct efficient ...

8

Sources and Magnitude of Intralaboratory Variability in a Sequence Based Genotypic Assay for Human Immunodeficiency Virus Type 1 Drug Resistance

Sources and Magnitude of Intralaboratory Variability in a Sequence Based Genotypic Assay for Human Immunodeficiency Virus Type 1 Drug Resistance

... virus type 1 (HIV-1) protease (PR) and reverse transcriptase (RT) by using replicate subanalyses of 46 plasma samples collected from HIV-1-infected, ...

8

Human immunodeficiency virus type 1 (HIV-1) protein Vif inhibits the activity of HIV-1 protease in bacteria and in vitro.

Human immunodeficiency virus type 1 (HIV-1) protein Vif inhibits the activity of HIV-1 protease in bacteria and in vitro.

... virus type 1 (HIV-1) encodes auxiliary proteins which are not found in oncoretroviruses but which influence HIV-1 replication ...among HIV-1-infected per- sons (20, ...

8

Characterization of human immunodeficiency virus type 1 dimeric RNA from wild-type and protease-defective virions.

Characterization of human immunodeficiency virus type 1 dimeric RNA from wild-type and protease-defective virions.

... In an effort to determine whether the dimers of full-length genomic RNA extracted from HIV-1 particles exhibit this property, we compared the thermal stability of HIV-1 dimeric RNAs in 1[r] ...

6

Intracellular expression of human immunodeficiency virus type 1 (HIV-1) protease variants inhibits replication of wild-type and protease inhibitor-resistant HIV-1 strains in human T-cell lines.

Intracellular expression of human immunodeficiency virus type 1 (HIV-1) protease variants inhibits replication of wild-type and protease inhibitor-resistant HIV-1 strains in human T-cell lines.

... prevent HIV-1 replication in individual cells are ...efficacies, HIV-1 replication occurs only in cells which do not express effective td PR ...on HIV-1 is minimal or nonexistent ...

8

High Degree of Interlaboratory Reproducibility of Human Immunodeficiency Virus Type 1 Protease and Reverse Transcriptase Sequencing of Plasma Samples from Heavily Treated Patients

High Degree of Interlaboratory Reproducibility of Human Immunodeficiency Virus Type 1 Protease and Reverse Transcriptase Sequencing of Plasma Samples from Heavily Treated Patients

... drug-resistant HIV-1 variants is ...reported protease codon 90 for patient PCC25 and protease codon 48 for patient PCC26 as being of the wild type (WT) because the mutant (Mut) ...

8

In vitro selection and characterization of human immunodeficiency virus type 1 (HIV-1) isolates with reduced sensitivity to hydroxyethylamino sulfonamide inhibitors of HIV-1 aspartyl protease.

In vitro selection and characterization of human immunodeficiency virus type 1 (HIV-1) isolates with reduced sensitivity to hydroxyethylamino sulfonamide inhibitors of HIV-1 aspartyl protease.

... that HIV-1 protease has the plasticity to sustain multiple sequence changes that result in reduced in- hibitor binding but not elimination of catalytic ...in HIV-1 protease that ...

9

Construction of a Human Immunodeficiency Virus Type 1 (HIV-1) Library Containing Random Combinations of Amino Acid Substitutions in the HIV-1 Protease due to Resistance by Protease Inhibitors

Construction of a Human Immunodeficiency Virus Type 1 (HIV-1) Library Containing Random Combinations of Amino Acid Substitutions in the HIV-1 Protease due to Resistance by Protease Inhibitors

... 30 protease recombinants of the HIV-1 pNG-PRL ...from HIV-1-infected MT-2 ...viral protease-encoding sequence was amplified by PCR with primers PR5 (5⬘-GTT AAG TGT TTC AAT TGT ...

7

Receptor-Triggered but Alkylation-Arrested Env of Murine Leukemia Virus Reveals the Transmembrane Subunit in a Prehairpin Conformation

Receptor-Triggered but Alkylation-Arrested Env of Murine Leukemia Virus Reveals the Transmembrane Subunit in a Prehairpin Conformation

... sponding HIV-1 gp41 peptide (16 ␮ M) ...the HIV-1 gp41 and avian leukosis virus TM ...not HIV-1, the LAS was found to be resistant to peptide inhibition (7, 17, 19, ...

5

Analysis of the mechanical properties of wild type and hyperstable mutants of the HIV 1 capsid

Analysis of the mechanical properties of wild type and hyperstable mutants of the HIV 1 capsid

... ΔEnv HIV-1 genome vector containing either the WT or E45A CA mutant sequence, using a method previ- ously described ...concentrated HIV-1 pseudovi- ral particles with an equal amount of ...

7

HIV protease inhibitors: a review of molecular selectivity and toxicity

HIV protease inhibitors: a review of molecular selectivity and toxicity

... of HIV, 26 anti-HIV compounds have been approved by the US Food and Drug Administration ...are HIV protease inhibitors. The combination therapy of HIV protease inhibitors, ...

10

Human Immunodeficiency Virus Type 1 Nucleocapsid Protein Nuclear Localization Mediates Early Viral mRNA Expression

Human Immunodeficiency Virus Type 1 Nucleocapsid Protein Nuclear Localization Mediates Early Viral mRNA Expression

... for HIV-1 spliced mRNA and cellular ␤-globin mRNA were as previously described (22, 28, ...for HIV-1 NC localization, were examined for early viral spliced mRNA ...

11

Show all 10000 documents...

Related subjects